Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis

Company Overview

Carl Zeiss Meditec AG is a global medical technology company specializing in ophthalmic and microsurgical solutions. As a subsidiary of the Carl Zeiss Group, the company focuses on the development, manufacturing and distribution of devices for eye care professionals, including diagnostic imaging systems, surgical microscopes and laser platforms. Its products are designed to support vision screening, cataract, glaucoma and refractive procedures, as well as a range of other ophthalmic treatments.

The company’s product portfolio includes optical coherence tomography (OCT) systems for high-resolution imaging of the retina, phacoemulsification units for cataract removal, intraocular lenses (IOLs) for implantation, and femtosecond lasers used in minimally invasive corneal and refractive surgery. In microsurgery, Carl Zeiss Meditec offers advanced surgical microscopes and visualization tools that enhance precision in neurosurgical, dental and plastic surgery settings. Many of its platforms integrate digital workflows, enabling seamless connectivity between preoperative diagnostics and operative guidance systems.

Founded on the legacy of Carl Zeiss dating back to 1846 in Jena, Germany, Carl Zeiss Meditec AG was established as a publicly traded entity in 2002 to consolidate the group’s medical technology activities. Headquartered in Jena and Munich, the company has cultivated a broad international presence, serving healthcare providers in Europe, North America, Asia-Pacific, Latin America and other regions. Its global network of sales offices, distributors and service centers ensures local support and training for clinicians and technicians.

Leadership at Carl Zeiss Meditec is committed to advancing innovative technologies that address unmet needs in eye care and surgery. Under the guidance of CEO Dr. Ludwin Monz, the company continues to invest in research and development, partnerships and digital health initiatives aimed at improving patient outcomes and streamlining clinical workflows. Carl Zeiss Meditec’s strategic priorities include expanding its diagnostic portfolio, enhancing surgical capabilities and driving adoption of data-driven solutions across ophthalmic and microsurgical markets.

Key Stats

• Today's Range: $59.27 to $60.99
• 50-Day Range: $59.29 to $71.73
• 52-Week Range: $46.13 to $80.09
• Volume: 3,144 shs
• Average Volume: 4,208 shs
• Market Capitalization: N/A
• P/E Ratio: 64.45
• Dividend Yield: 0.51%
• Price Target: N/A
• Consensus Rating: Hold

CZMWY Stock Analysis - Frequently Asked Questions

How have CZMWY shares performed this year?

Carl Zeiss Meditec's stock was trading at $47.50 at the beginning of the year. Since then, CZMWY shares have increased by 24.8% and is now trading at $59.29.

How do I buy shares of Carl Zeiss Meditec?

Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/15/2025
• Next Earnings (Estimated): 8/07/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CZMWY
• CIK: N/A
• Web: www.zeiss.com
• Phone: 493641220115
• Fax: N/A
• Employees: 4,823
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 64.45
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A